{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T14:11:19Z","timestamp":1771078279639,"version":"3.50.1"},"reference-count":28,"publisher":"Consilium Medicum","issue":"11","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Background. The most severe complications of antibiotic use are clostridial infection (CDI) and pseudomembranous colitis (PMC). There is a need for further study of these conditions and identification of their triggers.\r\nAim. To identify risk factors for severe forms of antibiotic-associated diarrhea caused by Clostridioides difficile.\r\nMaterials and methods. A clinical and laboratory examination of 440 patients with CDI who were treated at Botkin Clinical Infectious Diseases Hospital was conducted. CDI was confirmed by detection of toxins A and B of C. difficile in feces using enzyme-linked immunosorbent assay and immunochromatography. Metronidazole (2 g\/day, in patients without comorbid pathology) and vancomycin (0.5\u20132 g\/day) were used as a starting drug for up to 14 days. Statistical processing of the obtained data was performed using the Statistica for Windows, v.10 (StatSoft, USA) program.\r\nResults. CDI was confirmed by enzyme-linked immunosorbent assay in 202 (45.91%) patients, immunochromatography \u2013 in 149 (33.86%), endoscopically \u2013 in 203 (46.14%). CDI was most frequently recorded in 2 age groups of patients: 18\u201330 years old \u2013 in 137 (31.14%); over 60 years old \u2013 in 205 (46.59%). CDI was characterized by a combination of colitic and intoxication syndromes. In 43 (9.77%) patients the disease resulted in death. The diagnosis of PM\u0421 was established in 61 (13.86%) people. The risks of developing PMC when prescribing antibacterial drugs decreased in the following order: fluoroquinolones, cephalosporins, macrolides, penicillins, nitrofurans and chloramphenicol. Probiotic drugs reduced the risk of developing PMC (relative risk 0.5 [0.3; 0.7]; p=0.002).\r\nConclusion. PMC was characterized by a combination of diarrhea, intoxication and abdominal pain. The formation of PMC was preceded by courses of antibacterial drugs of the fluoroquinolone and cephalosporin groups, eradication therapy for Helicobacter infection, the use of high doses of glucocorticosteroids, as well as intestinal superinfection in patients with previous episodes of CDI.<\/jats:p>","DOI":"10.26442\/00403660.2024.11.203040","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T10:43:58Z","timestamp":1734345838000},"page":"1042-1048","source":"Crossref","is-referenced-by-count":1,"title":["Prediction of the course of antibiotic-associated diarrhea caused by &lt;i&gt;Clostridioides difficile&lt;\/i&gt; based on clinical and laboratory characteristics of the disease"],"prefix":"10.26442","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1730-8576","authenticated-orcid":false,"given":"Konstantin D.","family":"Ermolenko","sequence":"additional","affiliation":[{"name":"Pediatric Research and Clinical Center for Infectious Diseases"},{"name":"Saint Petersburg State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8604-9345","authenticated-orcid":false,"given":"Tatiana V.","family":"Potapova","sequence":"additional","affiliation":[{"name":"Pavlov First Saint Petersburg State Medical University"},{"name":"Botkin Clinical Infectious Diseases Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0264-9504","authenticated-orcid":false,"given":"Kseniia V.","family":"Silav","sequence":"additional","affiliation":[{"name":"Pediatric Research and Clinical Center for Infectious Diseases"},{"name":"Botkin Clinical Infectious Diseases Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3679-1874","authenticated-orcid":false,"given":"Konstantin V.","family":"Zhdanov","sequence":"additional","affiliation":[{"name":"Pediatric Research and Clinical Center for Infectious Diseases"},{"name":"Saint Petersburg State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3643-7354","authenticated-orcid":false,"given":"Dmitry A.","family":"Lioznov","sequence":"additional","affiliation":[{"name":"Pavlov First Saint Petersburg State Medical University"},{"name":"Smorodintsev Research Institute of Influenza"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9202-3231","authenticated-orcid":false,"given":"Denis A.","family":"Gusev","sequence":"additional","affiliation":[{"name":"Botkin Clinical Infectious Diseases Hospital"},{"name":"Almazov National Medical Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01867-1"},{"key":"ref2","unstructured":"\u0416\u0434\u0430\u043d\u043e\u0432 \u041a.\u0412., \u0417\u0430\u0445\u0430\u0440\u0435\u043d\u043a\u043e \u0421.\u041c., \u041b\u044c\u0432\u043e\u0432 \u041d.\u0418., \u041a\u043e\u0437\u043b\u043e\u0432 \u041a.\u0412. \u041f\u0440\u043e\u0442\u0438\u0432\u043e\u0434\u0435\u0439\u0441\u0442\u0432\u0438\u0435 \u0438\u043d\u0444\u0435\u043a\u0446\u0438\u044f\u043c \u0432 \u044d\u043f\u043e\u0445\u0443 \u0441\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u044b\u0445 \u0443\u0433\u0440\u043e\u0437. \u0418\u043d\u0444\u0435\u043a\u0446\u0438\u043e\u043d\u043d\u044b\u0435 \u0431\u043e\u043b\u0435\u0437\u043d\u0438: \u043d\u043e\u0432\u043e\u0441\u0442\u0438, \u043c\u043d\u0435\u043d\u0438\u044f, \u043e\u0431\u0443\u0447\u0435\u043d\u0438\u0435. 2017;6(23):85-91 [Zhdanov KV, Zakharenko SM, Lvov NI, Kozlov KV. Counteracting infections in the age of current threats. Infectious Diseases: News, Opinions, Training. 2017;6(23):85-91 (in Russian)]."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.26442\/terarkh20189011112-119"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00710-19"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2021.02.010"},{"key":"ref6","unstructured":"\u0417\u0430\u0445\u0430\u0440\u0435\u043d\u043a\u043e \u0421.\u041c. \u0410\u043d\u0442\u0438\u0431\u0438\u043e\u0442\u0438\u043a\u0438 \u0438 \u043f\u0440\u043e\u0431\u0438\u043e\u0442\u0438\u043a\u0438 \u0432 \u043f\u0440\u043e\u0444\u0438\u043b\u0430\u043a\u0442\u0438\u043a\u0435 \u0438 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u0434\u0438\u0430\u0440\u0435\u0438 \u043f\u0443\u0442\u0435\u0448\u0435\u0441\u0442\u0432\u0435\u043d\u043d\u0438\u043a\u043e\u0432. \u0418\u043d\u0444\u0435\u043a\u0446\u0438\u043e\u043d\u043d\u044b\u0435 \u0431\u043e\u043b\u0435\u0437\u043d\u0438. 2012;10(2):61-9 [Zakharenko SM. Antibiotiki i probiotiki v profilaktike i terapii diarei puteshestvennikov. Infektsionnye bolezni. 2012;10(2):61-9 (in Russian)]."},{"key":"ref7","unstructured":"\u0413\u043e\u043d\u0447\u0430\u0440 \u041d.\u0412., \u0415\u0440\u043c\u043e\u043b\u0435\u043d\u043a\u043e \u041a.\u0414., \u041a\u043b\u0438\u043c\u043e\u0432\u0430 \u041e.\u0418., \u0438 \u0434\u0440. \u0411\u0430\u043a\u0442\u0435\u0440\u0438\u0430\u043b\u044c\u043d\u044b\u0435 \u043a\u0438\u0448\u0435\u0447\u043d\u044b\u0435 \u0438\u043d\u0444\u0435\u043a\u0446\u0438\u0438 \u0441 \u0441\u0438\u043d\u0434\u0440\u043e\u043c\u043e\u043c \u0433\u0435\u043c\u043e\u043a\u043e\u043b\u0438\u0442\u0430 \u0443 \u0434\u0435\u0442\u0435\u0439: \u044d\u0442\u0438\u043e\u043b\u043e\u0433\u0438\u044f, \u043b\u0430\u0431\u043e\u0440\u0430\u0442\u043e\u0440\u043d\u0430\u044f \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0430 (\u043e\u0431\u0437\u043e\u0440). \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0430 \u044d\u043a\u0441\u0442\u0440\u0435\u043c\u0430\u043b\u044c\u043d\u044b\u0445 \u0441\u0438\u0442\u0443\u0430\u0446\u0438\u0439. 2019;21(1):92-104 [Gonchar NV, Ermolenko KD, Klimova OI, et al. Bacterial intestinal infections with hemocolitis syndrome in children: etiology, laboratory diagnosis (review). Medicine of Extreme Situations. 2019;21(1):92-104 (in Russian)]."},{"key":"ref8","unstructured":"\u0415\u0440\u043c\u043e\u043b\u0435\u043d\u043a\u043e \u041a.\u0414., \u0413\u043e\u043d\u0447\u0430\u0440 \u041d.\u0412., \u0415\u0440\u043c\u043e\u043b\u0435\u043d\u043a\u043e \u0415.\u0418., \u041b\u043e\u0431\u0437\u0438\u043d \u042e.\u0412. \u041d\u0430\u0440\u0443\u0448\u0435\u043d\u0438\u0435 \u043c\u0438\u043a\u0440\u043e\u0431\u0438\u043e\u0446\u0435\u043d\u043e\u0437\u0430 \u043a\u0438\u0448\u0435\u0447\u043d\u0438\u043a\u0430 \u043a\u0430\u043a \u0444\u0430\u043a\u0442\u043e\u0440 \u0444\u043e\u0440\u043c\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u044f \u043f\u043e\u0441\u0442\u0438\u043d\u0444\u0435\u043a\u0446\u0438\u043e\u043d\u043d\u043e\u0439 \u043f\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u043e\u0440\u0433\u0430\u043d\u043e\u0432 \u043f\u0438\u0449\u0435\u0432\u0430\u0440\u0435\u043d\u0438\u044f \u0443 \u0434\u0435\u0442\u0435\u0439 \u043f\u043e\u0441\u043b\u0435 \u0432\u0438\u0440\u0443\u0441\u043d\u044b\u0445 \u043a\u0438\u0448\u0435\u0447\u043d\u044b\u0445 \u0438\u043d\u0444\u0435\u043a\u0446\u0438\u0439. \u042d\u043a\u0441\u043f\u0435\u0440\u0438\u043c\u0435\u043d\u0442\u0430\u043b\u044c\u043d\u0430\u044f \u0438 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0433\u0430\u0441\u0442\u0440\u043e\u044d\u043d\u0442\u0435\u0440\u043e\u043b\u043e\u0433\u0438\u044f. 2017;1(137):53-7 [Ermolenko KD, Gonchar NV, Ermolenko EI, Lobzin YuV. Violations of gut microbiota as a factor of functional pathology of the digestive system in children after a viral intestinal infections. Experimental and Clinical Gastroenterology. 2017;(1):53-7 (in Russian)]."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2023.12.202496"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2019.11.000337"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21518\/2079-701X-2017-19-126-133"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.20333\/25000136-2022-6-38-44"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.17116\/terarkh2015875127-131"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112861"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01352-23"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00012"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp011603"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.22416\/1382-4376-2020-30-2-76-89"},{"key":"ref19","unstructured":"\u0417\u0430\u0445\u0430\u0440\u043e\u0432\u0430 \u041d.\u0412., \u0424\u0438\u043b\u044c \u0422.\u0421. \u041f\u0441\u0435\u0432\u0434\u043e\u043c\u0435\u043c\u0431\u0440\u0430\u043d\u043e\u0437\u043d\u044b\u0439 \u043a\u043e\u043b\u0438\u0442: \u043f\u0430\u0442\u043e\u0433\u0435\u043d\u0435\u0437, \u043f\u0440\u043e\u0444\u0438\u043b\u0430\u043a\u0442\u0438\u043a\u0430, \u043b\u0435\u0447\u0435\u043d\u0438\u0435. \u042d\u043a\u0441\u043f\u0435\u0440\u0438\u043c\u0435\u043d\u0442\u0430\u043b\u044c\u043d\u0430\u044f \u0438 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0433\u0430\u0441\u0442\u0440\u043e\u044d\u043d\u0442\u0435\u0440\u043e\u043b\u043e\u0433\u0438\u044f. 2013;12:87-91 [Zakharova NV, Fil TS. Pseudomembranous colitis: pathogenesis, prevention, treatment. Experimental and Clinical Gastroenterology. 2013;12:87-91 (in Russian)]."},{"key":"ref20","unstructured":"Natarajan M, Rogers MA, Bundy J, et al. Gender Differences in Non-Toxigenic Clostridium difficile Colonization and Risk of Subsequent C. difficile Infection. Clin Res Infect Dis. 2015;2(2):1017."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.22625\/2072-6732-2022-14-3-37-44"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-021-02267-x"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/17562848231170479"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/20499361231154443"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000626"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i42.7476"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"\u041f\u043e\u0442\u0430\u043f\u043e\u0432\u0430 \u0422.\u0412., \u0415\u0440\u043c\u043e\u043b\u0435\u043d\u043a\u043e \u041a.\u0414., \u041b\u0438\u043e\u0437\u043d\u043e\u0432 \u0414.\u0410. \u041f\u0441\u0435\u0432\u0434\u043e\u043c\u0435\u043c\u0431\u0440\u0430\u043d\u043e\u0437\u043d\u044b\u0439 \u043a\u043e\u043b\u0438\u0442: \u0444\u0430\u043a\u0442\u043e\u0440\u044b \u0440\u0438\u0441\u043a\u0430, \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u043a\u0430\u0440\u0442\u0438\u043d\u0430, \u043b\u0435\u0447\u0435\u043d\u0438\u0435. \u0424\u0430\u0440\u043c\u0430\u0442\u0435\u043a\u0430. 2018;2(355):64-8 [Potapova TV, Ermolenko KD, Lioznov DA. Pseudomembranous colitis: risk factors, clinical picture, treatment. Pharmateca. 2018;2(355):64-8 (in Russian)].","DOI":"10.18565\/pharmateca.2018.2.64-68"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.18565\/therapy.2023.10.74-82"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/637236\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/637236\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T10:44:34Z","timestamp":1734345874000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/637236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,12,16]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2024.11.203040","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,16]]}}}